REGULATED PRESS RELEASE published on 10/01/2025 at 18:15, 2 months 13 days ago Financial statements - 30 june 2025
BRIEF published on 09/23/2025 at 18:20, 2 months 21 days ago EXACOMPTA CLAIREFONTAINE Reports Decrease in H1 2025 Profits Financial Results Market Challenges Revenue Decline Operating Income Management Changes
REGULATED PRESS RELEASE published on 09/23/2025 at 18:15, 2 months 21 days ago Financial statements - 30 june 2025 EXACOMPTA CLAIREFONTAINE Board of Directors reviewed and approved Group financial statements for H1 2025 in Paris. Revenue down, operating income dropped, economic challenges noted Financial Statements Revenue Operating Income Exacompta Clairefontaine Economic Conditions
BRIEF published on 09/18/2025 at 18:20, 2 months 26 days ago EXACOMPTA CLAIREFONTAINE 2025 half-year report: declining results Half-year Results Turnover General Management Financial Debt Outlook 2025
REGULATED PRESS RELEASE published on 05/13/2025 at 18:11, 7 months 1 day ago DPEF - non financial performance declaration 2024
BRIEF published on 04/02/2025 at 18:10, 8 months 12 days ago EXACOMPTA CLAIREFONTAINE Reports 2024 Financial Results Market Conditions Revenue Decline Segment Performance Financial Results 2024 2025 Outlook
REGULATED PRESS RELEASE published on 04/02/2025 at 18:05, 8 months 12 days ago Financial statements - 31 december 2024 EXACOMPTA CLAIREFONTAINE Board of Directors approved 2024 financial statements. Revenue: €831,274,000. Outlook cautious due to weak Q1 2025 demand Financial Statements Revenue Outlook 2024 Exacompta Clairefontaine
BRIEF published on 03/27/2025 at 18:05, 8 months 18 days ago EXACOMPTA CLAIREFONTAINE: 2024 annual results and 2025 outlook Stationery Market 2024 Results Outlook 2025 Dividend Share Paper Production
BRIEF published on 03/03/2025 at 18:05, 9 months 11 days ago Voting Rights and Shares 2024: Exacompta Clairefontaine Report Share Capital Voting Rights Actions Financial Market Exacompta Clairefontaine
Published on 12/15/2025 at 15:00, 1 hour 9 minutes ago Kingfisher Reports Annual General Meeting Voting Results
Published on 12/15/2025 at 15:00, 1 hour 9 minutes ago Jaguar Health Announces Abstract Submission for Preliminary Data from US Investigator-Initiated Trial of Crofelemer in Adult Patients with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
Published on 12/15/2025 at 14:30, 1 hour 39 minutes ago Unusual Machines Congratulates Customers Selected for the Army's PBAS Tranche 1.1, Including Envision Technology and Strategic Logix
Published on 12/15/2025 at 14:00, 2 hours 9 minutes ago Dateline Delivers Further High-Grade Intercepts from North Pipe at Colosseum
Published on 12/15/2025 at 13:30, 2 hours 39 minutes ago Greenlane Announces Results of Annual Meeting of Stockholders, Canopy Growth Co Founder Bruce Linton Joins Greenlane's Board of Directors
Published on 12/15/2025 at 15:50, 19 minutes ago Original-Research: Cabka N.V. (von First Berlin Equity Research GmbH): Kaufen
Published on 12/15/2025 at 15:49, 20 minutes ago Mutares submits an irrevocable offer to acquire Venator Ultramarine Blue Pigments business from Venator France SAS
Published on 12/15/2025 at 15:45, 24 minutes ago Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated
Published on 12/15/2025 at 15:44, 24 minutes ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
Published on 12/15/2025 at 15:43, 25 minutes ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc
Published on 12/15/2025 at 11:50, 4 hours 19 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of November 30, 2025
Published on 12/12/2025 at 18:00, 2 days 22 hours ago Disclosure of trading in own shares between November 24th and November 28th, 2025
Published on 12/11/2025 at 08:30, 4 days 7 hours ago Edenred and Daimler Truck join forces to accelerate the rollout of charging infrastructure for electric trucks in Europe